Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Amgen exercised a third option for an exclusive, worldwide license to use ImmunoGen's Targeted Antibody Payload (TAP) technology to develop cancer therapeutics to an undisclosed target. TAP technology...